SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001144204-12-067286
Filing Date
2012-12-10
Accepted
2012-12-10 17:26:40
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT v329695_424b4.htm 424B4 3566986
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC logo_northwestbio.jpg GRAPHIC 8180
5 GRAPHIC v327138_ifc1.jpg GRAPHIC 108104
6 GRAPHIC v327138_ifc2.jpg GRAPHIC 156272
7 GRAPHIC v327138_diagram1.jpg GRAPHIC 111159
8 GRAPHIC v327138_diagram2.jpg GRAPHIC 94730
9 GRAPHIC v327138_freesurvival.jpg GRAPHIC 43151
10 GRAPHIC v327138_overallsurvival.jpg GRAPHIC 43990
  Complete submission text file 0001144204-12-067286.txt   4348717
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-182470 | Film No.: 121254258
SIC: 2834 Pharmaceutical Preparations